Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.98 +1.28%

+$0.16 today

Market cap
$150.57M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.23M

Average 0.35M

Income Statement

Follow revenue through to earnings.

Revenue

$18.62M

FY 2025 · Annual

Operating Income

-$76.81M

FY 2025 · Annual

Net Income

-$76.68M

FY 2025 · Annual

RNA Earnings Waterfall · TTM

NASDAQ:RNA · Revenue to Net Income

No earnings data available.

Competitors

Peer companies in the same sector

Health

No competitor data available.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
8-KCurrent reportNov 12, 2026
10-QQuarterly reportNov 12, 2026
8-KCurrent reportNov 2, 2026
8-KCurrent reportOct 27, 2026
8-K/A8-K/A filingOct 9, 2026

How much revenue does RNA generate?

Atrium Therapeutics, Inc. (RNA) reported $18.62M of revenue in fiscal 2025.

Is RNA profitable?

Atrium Therapeutics, Inc. (RNA) reported -$76.68M of net income, with a net margin of -411.9%.